
TBS played a vital role in facilitating research related to the biology of cervical cancer and exploring new approaches and strategies for patient management. The introduction of TBS terminology of “atypical squamous cells of undetermined significance” (ASCUS) highlighted the inherent limitations of morphologic interpretation.
The Pap test and Bethesda 2014 - Nayar - 2015 - Cancer …
2015年5月1日 · TBS played a vital role in facilitating research related to the biology of cervical cancer and exploring new approaches and strategies for patient management. The introduction of TBS terminology of “atypical squamous cells of undetermined significance” (ASCUS) highlighted the inherent limitations of morphologic interpretation.
The Bethesda System for reporting cervical cytology - PMC
The TBS 2014 includes a chapter on anal cytology which was also included in the 2001 Bethesda atlas. New insights into anal cancer epidemiology are explained along with morphological findings. A separate chapter on adjunctive testing has been added to reflect the advances in HPV testing methods and immunocytochemistry methods.
TBS子宫颈细胞学报告系统回顾及新版解读 - ipathology
2019年4月4日 · TBS-2014版中的相关辅助检测报告方案是指HPV检测方案及 hr-HPV感染引致的细胞周期异常标志物如p16、 ProExC和Ki67的免疫细胞化学标记。 随着HPV检测在宫颈癌筛查中的应用,出现了一些子宫颈细胞学终结的声音。
The Effects of the Bethesda System 2014 on Endometrial Cell
The implementation of TBS 2014 reduced the frequency of reporting benign-appearing endometrial cells. The follow-up biopsy rate has remained essentially the same, but the total number of biopsies performed decreased, with a similar low yield of significant abnormalities.
2014年宫颈细胞学Bethesda报告系统(中英对照) - ipathology
2017年5月24日 · 在报告简要说明检测方法和检测结果,使临床容易理解。 若用自动仪器检测,注明仪器类型和检测结果。 建议应当准确并符合专业机构出版的临床随访指南(可包括相关的参考文献)。 声明:仅用于学术和交流,不得用于商业活动。 Ritu Nayar,David C. Wilbur,Editors. The Bethesda System for Reporting Cervical Cytology, Definitions, Criteria, and Explanatory Notes, Third Edition. 本站欢迎原创文章投稿,来稿一经采用稿酬从优,投稿邮箱 …
Updates in Cervical Cancer Screening Guidelines, The Bethesda …
The major changes in TBS 2014 included the following: the reporting of benign appearing endometrial cells for women ≥45 years old, instead of women ≥40 years old; “low-grade squamous intraepithelial lesion (LSIL), cannot exclude high-grade intraepithelial squamous lesion (HSIL)” is not recommended, etc.
TBS报告系统 - 百度文库
tbs报告系统-高度鳞状上皮内病变 (hsil) 定义:包括中度和重度异型增生、宫颈上皮内瘤变 (cin2/3)、原位鳞癌。 细胞形态学特征:胞核增大,因胞质减少导致核质 比显著增加,染色质深染、粗糙,核膜不规则明显。
Reporting of Benign Endometrial Cells in Papanicolaou Tests
2020年5月14日 · The 2014 Bethesda System (TBS 2014) guidelines for reporting cervical cytology revised the age for reporting benign endometrial cells (BECs) from 40 years or older to age 45 years or older. We evaluated this change and further investigated if extending the reporting age to 50 years or older may be acceptable.
TBS子宫颈细胞学报告系统回顾及新版解读 - 道客巴巴
2017年2月2日 · 基于 TBS 的关键原则,标准化的术语已经发展至身体其他部位的细胞学包括甲状腺,胰腺和尿液细胞学。 TBS 的两级术语 2014 年也被 WHO、ASCCP 和美国病理学会推荐用于肛门及下生殖道 HPV 相关鳞状上皮病变的组织病理学报告 [5-6] 。 三、TBS-2014 更新及第三版图集发行2014年TBS进行第三次更新,第三版图集 相伴诞生 [7] 。